Once more, risk scores were significantly and favorably correlated with the majority of the critical stages of the tumor immune cycle, such as the release of cancer cell antigen (step 1), presentation of cancer antigen (step 2), priming and activation (step 3), immune cell transporting to the tumor (step 4) (CD8 T cell recruitment, Th1 cell recruitment, Th22 cell recruitment, NK cell recruitment, and Th17 cell recruitment), infiltration of immune cells into tumors (step 5), and recognition of cancer (Figure 10B). This evidence concerns the gene CD8A and cancer.